Vitamin E amides, a new class of vitamin E analogues with enhanced proapoptotic activity

International Journal of Cancer

Volumn 117, Issue 2, 2005, Pages 188-193

  Tomic Vatic, Adisa ^a   EyTina, John ^b   Chapman, James ^b   Mahdavian, Elahe ^c   Neuzil, Jiri ^a,d   Salvatore, Brian A ^c  

^a GRIFFITH UNIVERSITY   (Australia)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c LOUISIANA STATE UNIVERSITY   (United States)

^d INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

Author keywords

Anticancer agents; Apoptosis; Mitochondrial destabilization; Vitamin E amides

Indexed keywords

ALPHA TOCOPHEROL AMIDE; ALPHA TOCOPHEROL DERIVATIVE; ALPHA TOCOPHEROL SUCCINATE; ALPHA TOCOPHERYLMALEYLAMIDE; ALPHA TOCOPHERYLSUCCINYLAMIDE; AMIDE; ANTINEOPLASTIC AGENT; CARBOXYLIC ACID DERIVATIVE; DICHLOROMETHANE; GREEN FLUORESCENT PROTEIN; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN MCL 1; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG STRUCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MEMBRANE POTENTIAL; METHYLATION; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; THIN LAYER CHROMATOGRAPHY;

APOPTOSIS; CELL SURVIVAL; FLOW CYTOMETRY; HUMANS; INTRACELLULAR MEMBRANES; JURKAT CELLS; KINETICS; MEMBRANE POTENTIALS; MITOCHONDRIA; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP; VITAMIN E;

EID: 25444495051     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.21171     Document Type: Article

References (41)

1. Nam NH, Parang K. Current targets for anticancer drug discovery. Curr Drug Targets 2003;4:159-219.
2. Neuzil J, Kagedal K, Andera L, Weber C, Brunk UT. Vitamin E analogs: a new class of multiple action agents with anti-neoplastic and anti-atherogenic activity. Apoptosis 2002;7:179-87.
3. Qian M, Kralova J, Yu W, Bose HR, Dvorak M, Sanders BG, Kline K. c-Jun involvement in vitamin E succinate induced apoptosis of reticuloendotheliosis virus transformed avian lymphoid cells. Oncogene 1997;15:223-30.
4. Pussinen PJ, Lindner H, Glatter O, Reicher H, Kostner GM, Wintersperger A, Malle E, Sattler W. Lipoprotein-associated α-tocopheryl-succinate inhibits cell growth and induces apoptosis in human MCF-7 and HBL-100 breast cancer cells. Biochim Biophys Acta 2000; 1485:129-44.
5. Neuzil J, Weber T, Gellert N, Weber C. Selective cancer cell killing by α-tocopheryl succinate. Br J Cancer 2001;84:87-9.
6. Neuzil J, Tomasetti M, Mellick A, Alleva R, Salvatore BA, Birringer M, Fariss MW. Vitamin E analogues: a new class of inducers of apoptosis with selective anti-cancer effect. Curr Cancer Drug Targets 2004;4:267-84.
7. Weber T, Dalen H, Andera L, Negre-Salvayre A, Auge N, Sticha M, Lloret A, Terman A, Witting PK, Higuchi M, Plasilova M, Zivny J, Gellert N, Weber C, Neuzil J. Mitochondria play a central role in apoptosis induced by α-tocopheryl succinate, an agent with antineoplastic activity: comparison with receptor-mediated pro-apoptotic signaling. Biochemistry 2003;42:4277-91.
8. Costantini P, Jacotot E, Decaudin D, Kroemer G. Mitochondrion as a novel target of anticancer chemotherapy. J Natl Cancer Inst 2000;92: 1042-53.
9. Hockenbery DM, Giedt CD, O'Neill JW, Manion MK, Banker DE. Mitochondria and apoptosis: new therapeutic targets. Adv Cancer Res 2002;85:203-42.
10. Yamamoto S, Tamai H, Ishisaka R, Kanno T, Arita K, Kobuchi H, Utsumi K. Mechanism of α-tocopheryl succinate-induced apoptosis of promyelocytic leukemia cells. Free Radic Res 2000;33:407-18.
11. Neuzil J, Zhao M, Ostermann G, Sticha M, Gellert N, Weber C, Eaton JW, Brunk UT. α-tocopheryl succinate, an agent with in vivo antitumour activity, induces apoptosis by causing lysosomal instability. Biochem J 2002;362:709-15.
12. Li W, Yuan X, Nordgren G, Dalen H, Dubowchik GM, Firestone RA, Brunk UT. Induction of cell death by the lysosomotropic detergent MSDH. FEBS Lett 2000;470:35-9.
13. Yerushalmi B, Dahl R, Devereaux MW, Gumpricht E, Sokol RJ. Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition. Hepatology 2001;33:616-26.
14. Neuzil J, Svensson I, Weber T, Weber C, Brunk UT. α-tocopheryl succinate-induced apoptosis in Jurkat T cells involves caspase-3 activation, and both lysosomal and mitochondrial destabilisation. FEBS Lett 1999;445:295-300.
15. Kuwana T, Mackey MR, Perkins G, Ellisman MH, Latterich M, Schneiter R, Green DR, Newmeyer DD. Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 2002;111:331-42.
16. Siskind LJ, Kolesnick RN, Colombini M. Ceramide channels increase the permeability of the mitochondrial outer membrane to small proteins. J Biol Chem 2002;277:26796-803.
17. De Giorgi F, Lartigue L, Bauer MK, Schubert A, Grimm S, Hanson GT, Remington SJ, Youle RJ, Ichas F. The permeability transition pore signals apoptosis by directing Bax translocation and multimerization. FASEB J 2002;16:607-9.
18. Neuzil J, Weber T. Schroder A, Lu M, Ostermann G, Gellert N, Mayne GC, Olejnicka B, Negre-Salvayre A, Sticha M, Coffey RJ, Weber C. Induction of cancer cell apoptosis by α-tocopheryl succinate: molecular pathways and structural requirements. FASEB J 2001;15:403-15.
19. Birringer M, EyTina J, Salvatore BA, Neuzil J. Vitamin E analogues as inducers of apoptosis: structure-function relation-ship. Br J Cancer 2003;88:1948-55.
20. Turley JM, Ruscetti FW, Kim SJ, Fu T, Gou FV, Birchenall-Roberts MC. Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: increased binding of cyclin A negatively regulates E2F transactivation activity. Cancer Res 1997;57:2668-75.
21. 2-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-α-tocopheryl succinate-induced apoptosis of human breast cancer cells. Cancer Res 2001;61:6569-76.
22. Zhang Y, Ni J, Messing EM, Chang E, Yang CR, Yeh S. Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells. Proc Natl Acad Sci USA 2002;99:7408-13.
23. Smith, LI, Renfrow, WB, Opie JW. The chemistry of vitamin E. XXXVIII. α-Tocopheramine, a new vitamin E factor. J Am Chem Soc 1942;64:1082-4.
24. Pass HI, Stevens EJ, Oie H, Tsokos MG, Abati AD, Fetsch PA, Mew DJ, Pogribniak HW, Matthews WJ. Characteristics of nine newly derived mesothelioma cell line. Ann Thorac Surg 1995;59: 835-44.
25. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res 1987;47:943-6.
26. Boersma AWM, Nooter K, Oostrum RG, Stoter G. Quantification of apoptotic cells with fluorescein isothiocyanate-labeled annexin V in Chinese hamster ovary cell cultures treated with cisplatin. Cytometry 1996;24:123-30.
27. Wolter KG, Hsu YT, Smith CL, Nechushtan A, Xi XG, Youle RJ. Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol 1997;139:1281-92.
28. Weber T, Lu M, Andera L, Lahm H, Gellert N, Fariss MW, Korinek V, Sattler W, Ucker DS, Terman A, Schröder A, Erl W, Brunk U, Coffey RJ, Weber C, Neuzil J. Vitamin E succinate is a potent novel anti-neoplastic agent with high tumor selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL. Apo2L) in vivo. Clin Cancer Res 2002;8:863-9.
29. Barnett KT, Fokum FD, Malafa MP. Vitamin E succinate inhibits colon cancer liver metastases. J Surg Res 2002;106:292-8.
30. Wang XF, Witting PK, Salvatore BA, Neuzil J. α-tocopheryl succinate induces apoptosis in HER2/erbB2-overexpressing breast cancer cells by signalling via the mitochondrial pathway. Biochem Biophys Res Commun 2005;326:282-9.
31. Yu W, Sanders BG, Kline K. RRR-α-tocopheryl succinate-induced apoptosis of human breast cancer cells involves Bax translocation to mitochondria. Cancer Res 2003;63:2483-91.
32. Estronca LM, Moreno MJ, Abreu MS, Melo E, Vaz WL. Solubility of amphiphiles in membranes: influence of phase properties and amphiphile head group. Biochem Biophys Res Commun 2002; 296:596-603.
33. Kurihara T, Motohashi N, Sakagami H, Molnar J. Relationship between cytotoxic activity and dipole moment for phthalimido- and chloroethyl- phenothiazines. Anticancer Res 1999;19:4081-3.
34. Dabenni-Sala F, Schiavo G, Palatini P. Mechanism of local anesthetic effect on mitochondrial ATP synthase as deduced from photolabeling and inhibition studies with phenothiazine derivatives. Biochim Biophys Acta 1990;1026:117-25.
35. van De Waterbeemd H, Smith DA, Beaumont K, Walker DK. Property-based design: optimization of drug absorption and pharmacokinetics. J Med Chem 2001;44:1313-33.
36. Barlow RB, Bremner JB, Soh KS. The effects of replacing ester by amide on the biological properties of compounds related to acetylcholine. Br J Pharmacol 1978;62:39-50.
37. Sugawara M, Huang W, Fei Y-J, Leibach FH, Ganapathy V, Ganapathy ME. Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2. J Pharm Sci 2000;89:781-9.
38. Malafa MP, Neitzel LT. Vitamin E succinate promotes breast cancer tumor dormancy. J Surg Res 2000;93:163-70.
39. Malafa MP, Fokum FD, Mowlavi A, Abusief M, King M. Vitamin E inhibits melanoma growth in mice. Surgery 2002;131:85-91.
40. Malafa MP, Fokum FD, Smith L, Louis A. Inhibition of angiogenesis and promotion of melanoma dormancy by vitamin E succinate. Ann Surg Oncol 2002;9:1023-32.
41. Tomasetti M, Gellert N, Procopio A, Neuzil J. A vitamin E analogue suppresses malignant mesothelioma in a pre-clinical model: a prototype of a future drug against a fatal neoplastic disease? Int J Cancer 2004;109:641-2.